SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ronald P.J. Oude Elferink, Ruth Bolier, Ulrich H. Beuers, Lysophosphatidic acid and signaling in sensory neurons, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2014,

    CrossRef

  2. 2
    Andreas E. Kremer, Jamison Feramisco, Peter W. Reeh, Ulrich Beuers, Ronald P.J. Oude Elferink, Receptors, cells and circuits involved in pruritus of systemic disorders, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014, 1842, 7, 869

    CrossRef

  3. 3
    Nora Bergasa, Itch, 2014,

    CrossRef

  4. 4
    Leila Moezi, Ahmad R. Dehpour, Cardiovascular abnormalities in obstructive cholestasis: the possible mechanisms, Liver International, 2013, 33, 1
  5. 5
    Victoria Kronsten, Emer Fitzpatrick, Alastair Baker, Management of Cholestatic Pruritus in Paediatric Patients With Alagille Syndrome, Journal of Pediatric Gastroenterology and Nutrition, 2013, 57, 2, 149

    CrossRef

  6. 6
    Mehrak Javadi-Paydar, Bentolhoda Ghiassy, Shohreh Ebadian, Nastaran Rahimi, Abbas Norouzi, Ahmad R. Dehpour, Nitric oxide mediates the beneficial effect of chronic naltrexone on cholestasis-induced memory impairment in male rats, Behavioural Pharmacology, 2013, 24, 3, 195

    CrossRef

  7. 7
    Asma Siddique, Kris V. Kowdley, Approach to a Patient with Elevated Serum Alkaline Phosphatase, Clinics in Liver Disease, 2012, 16, 2, 199

    CrossRef

  8. 8
    Cihan Yurdaydin, Kevin D. Mullen, Nora V. Bergasa, E. Anthony Jones, M.D., Liver International, 2012, 32, 5
  9. 9
    Mohamad H Imam, Andrea A Gossard, Emmanouil Sinakos, Keith D Lindor, Pathogenesis and management of pruritus in cholestatic liver disease, Journal of Gastroenterology and Hepatology, 2012, 27, 7
  10. 10
    Chalermrat Bunchorntavakul, K. Rajender Reddy, Pruritus in Chronic Cholestatic Liver Disease, Clinics in Liver Disease, 2012, 16, 2, 331

    CrossRef

  11. 11
    Douglas L. Nguyen, Nicholas F. LaRusso, Konstantinos N. Lazaridis, Blumgart's Surgery of the Liver, Pancreas and Biliary Tract, 2012,

    CrossRef

  12. 12
    Marco Carbone, James Neuberger, Liver transplantation in PBC and PSC: Indications and disease recurrence, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 6-7, 446

    CrossRef

  13. 13
    Andreas E. Kremer, Ronald P.J. Oude Elferink, Ulrich Beuers, Pathophysiology and current management of pruritus in liver disease, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 2, 89

    CrossRef

  14. 14
    Bhavik M. Bhandari, Hasan Bayat, Kenneth D. Rothstein, Primary Biliary Cirrhosis, Gastroenterology Clinics of North America, 2011, 40, 2, 373

    CrossRef

  15. 15
    Klaus Eisendle, Hansgeorg Müller, Elisabeth Ortner, Heribert Talasz, Ivo Graziadei, Wolfgang Vogel, Reinhard Höpfl, Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease, Journal of Gastroenterology and Hepatology, 2011, 26, 4
  16. 16
    Nora V. Bergasa, The Itch of Liver Disease, Seminars in Cutaneous Medicine and Surgery, 2011, 30, 2, 93

    CrossRef

  17. 17
    Xian-Yu Liu, Zhong-Chun Liu, Yan-Gang Sun, Michael Ross, Seungil Kim, Feng-Fang Tsai, Qi-Fang Li, Joseph Jeffry, Ji-Young Kim, Horace H. Loh, Zhou-Feng Chen, Unidirectional Cross-Activation of GRPR by MOR1D Uncouples Itch and Analgesia Induced by Opioids, Cell, 2011, 147, 2, 447

    CrossRef

  18. 18
    Zbigniew. Zylicz, Małgorzata Krajnik, Supportive Oncology, 2011,

    CrossRef

  19. 19
    Ghulam Abbas, Roberta A. Jorgensen, Keith D. Lindor, Fatigue in primary biliary cirrhosis, Nature Reviews Gastroenterology & Hepatology, 2010,

    CrossRef

  20. 20
    Mitsutoshi Tominaga, Kenji Takamori, Recent advances in pathophysiological mechanisms of itch, Expert Review of Dermatology, 2010, 5, 2, 197

    CrossRef

  21. 21
    Franco Marinangeli, Cristiana Guetti, Chiara Angeletti, Cristina Bonetti, Antonella Paladini, Alba Piroli, Giustino Varrassi, Intravenous Naloxone Plus Transdermal Buprenorphine in Cancer Pain Associated with Intractable Cholestatic Pruritus, Journal of Pain and Symptom Management, 2009, 38, 4, e5

    CrossRef

  22. 22
    Keith D. Lindor, M. Eric Gershwin, Raoul Poupon, Marshall Kaplan, Nora V. Bergasa, E. Jenny Heathcote, Primary biliary cirrhosis, Hepatology, 2009, 50, 1
  23. 23
    Andreas Binder, Jana Koroschetz, Ralf Baron, Disease mechanisms in neuropathic itch, Nature Clinical Practice Neurology, 2008, 4, 6, 329

    CrossRef

  24. 24
    E Anthony Jones, Pruritus and fatigue associated with liver disease: is there a role for ondansetron?, Expert Opinion on Pharmacotherapy, 2008, 9, 4, 645

    CrossRef

  25. 25
    Nora V. Bergasa, Pruritus in Primary Biliary Cirrhosis: Pathogenesis and Therapy, Clinics in Liver Disease, 2008, 12, 2, 385

    CrossRef

  26. 26
    Nora V. Bergasa, Update on the Treatment of the Pruritus of Cholestasis, Clinics in Liver Disease, 2008, 12, 1, 219

    CrossRef

  27. 27
    Parisa Hasanein, Mohsen Parviz, Mansoor Keshavarz, Kazem Javanmardi, Mohammad Allahtavakoli, Majid Ghaseminejad, Modulation of cholestasis-induced antinociception in rats by two NMDA receptor antagonists: MK-801 and magnesium sulfate, European Journal of Pharmacology, 2007, 554, 2-3, 123

    CrossRef

  28. 28
    Annarosa Floreani, Isabella Carderi, Angela Variola, Erik Rosa Rizzotto, James Nicol, Nora V. Bergasa, A novel multidrug-resistance protein 2 gene mutation identifies a subgroup of patients with primary biliary cirrhosis and pruritus, Hepatology, 2006, 43, 5
  29. 29
    Tajemah Mombeini, Farshad Roushanzamir, Masoumeh Jorjani, Zahra Pourpak, Seyed Ali Gaskari, Shahram Ejtemaie Mehr, Ahmad Reza Dehpour, Alteration in specific opioid-receptor labeling on peripheral blood leukocytes of bile duct-ligated rat, Pathophysiology, 2006, 13, 2, 111

    CrossRef

  30. 30
    Catherine Brigman, Andrew Feranchak, Liver involvement in cystic fibrosis, Current Treatment Options in Gastroenterology, 2006, 9, 6, 484

    CrossRef

  31. 31
    Nora V. Bergasa, Medical Palliation of the Jaundiced Patient with Pruritus, Gastroenterology Clinics of North America, 2006, 35, 1, 113

    CrossRef

  32. 32
    M. A. BABATIN, F. M. SANAI, M. G. SWAIN, Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy, Alimentary Pharmacology & Therapeutics, 2006, 24, 5
  33. 33
    Nora V. Bergasa, Commentary 7, Experimental Dermatology, 2005, 14, 3
  34. 34
    Alejandra G. Villamil, Juan C. Bandi, Omar A. Galdame, Solange Gerona, Adrian C. Gadano, Efficacy of lidocaine in the treatment of pruritus in patients with chronic cholestatic liver diseases, The American Journal of Medicine, 2005, 118, 10, 1160

    CrossRef

  35. 35
    Anjeli Krishnan, John Koo, Psyche, opioids, and itch: therapeutic consequences, Dermatologic Therapy, 2005, 18, 4
  36. 36
    Nora V. Bergasa, The pruritus of cholestasis, Journal of Hepatology, 2005, 43, 6, 1078

    CrossRef

  37. 37
    JEFFREY S. CRIPPIN, Transplantation of the Liver, 2005,

    CrossRef

  38. 38
    JAYANT A. TALWALKAR, W. RAY KIM, E. ROLAND DICKSON, Transplantation of the Liver, 2005,

    CrossRef

  39. 39
    Nora V Bergasa, An approach to the management of the pruritus of cholestasis, Clinics in Liver Disease, 2004, 8, 1, 55

    CrossRef

  40. 40
    Velimir A Luketic, Mitchell L Shiffman, Benign recurrent intrahepatic cholestasis, Clinics in Liver Disease, 2004, 8, 1, 133

    CrossRef

  41. 41
    Albert Pares, Laura Cisneros, Joan M. Salmeron, Llorenc Caballeria, Antoni Mas, Albert Torras, Juan Rodes, Extracorporeal Albumin Dialysis: A Procedure for Prolonged Relief of Intractable Pruritus in Patients with Primary Biliary Cirrhosis, The American Journal of Gastroenterology, 2004, 99, 6, 1105

    CrossRef

  42. 42
    Adrian Reuben, Old scratch, Hepatology, 2004, 39, 3
  43. 43
    Nora V. Bergasa, Treatment of the pruritus of cholestasis, Current Treatment Options in Gastroenterology, 2004, 7, 6, 501

    CrossRef

  44. 44
    Gitit Tomer, Benjamin L Shneider, Disorders of bile formation and biliary transport, Gastroenterology Clinics of North America, 2003, 32, 3, 839

    CrossRef

  45. 45
    Szilvia Szarvas, Dominic Harmon, Damian Murphy, Neuraxial opioid-induced pruritus: a review, Journal of Clinical Anesthesia, 2003, 15, 3, 234

    CrossRef

  46. 46
    L. BOSONNET, Pruritis: scratching the surface, European Journal of Cancer Care, 2003, 12, 2
  47. 47
    Nora V Bergasa, Pruritus and fatigue in primary biliary cirrhosis, Clinics in Liver Disease, 2003, 7, 4, 879

    CrossRef

  48. 48
    Nora V. Bergasa, Studying pruritus in the 21st century, Clinical Gastroenterology and Hepatology, 2003, 1, 4, 249

    CrossRef

  49. 49
    Alan R Gingold, Nora V Bergasa, The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis, Life Sciences, 2003, 73, 21, 2741

    CrossRef

  50. 50
    Seyed Ali Gaskari, Ali Reza Mani, Shahram Ejtemaei-Mehr, Khodadad Namiranian, Houman Homayoun, Hossein Ahmadi, Ahmad Reza Dehpour, Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis?, Fundamental & Clinical Pharmacology, 2002, 16, 4
  51. 51
    Rubén Terg, Emma Coronel, Juan Sordá, Alberto E Muñoz, Jorge Findor, Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study, Journal of Hepatology, 2002, 37, 6, 717

    CrossRef

  52. 52
    Robert H. Squires, End-stage liver disease in children, Current Treatment Options in Gastroenterology, 2001, 4, 5, 409

    CrossRef

  53. 53
    A. Parés, Ll. Caballería, Colestasis crónica del adulto, Medicine - Programa de Formación Médica Continuada Acreditado, 2000, 8, 9, 459

    CrossRef

  54. 54
    Ahmad Reza Dehpour, Morteza Samini, Hossein Rastegar, Abazar Jamshidi Ardeshiri, Farshad Roushanzamir, Masoumeh Jorjani, Abolhassan Ahmadiani, Effect of NMDA receptor antagonist on naloxone-precipitated withdrawal signs in cholestatic mice, Human Psychopharmacology: Clinical and Experimental, 2000, 15, 3
  55. 55
    Yasushi Kuraishi, Tomomi Yamaguchi, Takayuki Miyamoto, Itch-scratch responses induced by opioids through central Mu opioid receptors in mice, Journal of Biomedical Science, 2000, 7, 3, 248

    CrossRef

  56. 56
    Sammy Saab, Steven-Huy Han, Paul Martin, LIVER TRANSPLANTATION, Clinics in Liver Disease, 2000, 4, 3, 513

    CrossRef

  57. 57
    Anthony Kelly, Catherine Nelson-Piercy, Obstetric cholestasis, The Obstetrician & Gynaecologist, 2000, 2, 3
    Direct Link:
  58. 58
    Nora V Bergasa, Jay K Mehlman, E.Anthony Jones, Pruritus and fatigue in primary biliary cirrhosis, Best Practice & Research Clinical Gastroenterology, 2000, 14, 4, 643

    CrossRef

  59. 59
    Nora V. Bergasa, E.Anthony Jones, Reply, Journal of the American Academy of Dermatology, 2000, 43, 2, 325

    CrossRef

  60. 60
    A. R. Dehpour, H. R. Sadeghipour, A. Nowroozi, N. Akbarloo, The effect of the serotonergic system on opioid withdrawal-like syndrome in a mouse model of cholestasis, Human Psychopharmacology: Clinical and Experimental, 2000, 15, 6
  61. 61
    Velimir A. Luketic, Mitchell L. Shiffman, BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS, Clinics in Liver Disease, 1999, 3, 3, 509

    CrossRef

  62. 62
    Elizabeth A. Fagan, INTRAHEPATIC CHOLESTASIS OF PREGNANCY, Clinics in Liver Disease, 1999, 3, 3, 603

    CrossRef

  63. 63
    José Franco, Pruritus, Current Treatment Options in Gastroenterology, 1999, 2, 6, 451

    CrossRef

  64. 64
    E. Weisshaar, B. Ziethen, F.-W. Röhl, H. Gollnick, The antipruritic effect of a 5-HT3 receptor antagonist (tropisetron) is dependent on mast cell depletion – an experimental study, Experimental Dermatology, 1999, 8, 4
  65. 65
    Kent Aftergut, Clay J. Cockerell, UPDATE ON THE CUTANEOUS MANIFESTATIONS OF HIV INFECTION, Dermatologic Clinics, 1999, 17, 3, 445

    CrossRef

  66. 66
    Baruch Yerushalmi, Ronald J. Sokol, Michael R. Narkewicz, Debra Smith, Frederick M. Karrer, Use of Rifampin for Severe Pruritus in Children with Chronic Cholestasis, Journal of Pediatric Gastroenterology & Nutrition, 1999, 29, 4, 442

    CrossRef

  67. 67
    Ahmad Reza Dehpour, Farnoush Meysami, Naser Ebrahimi-Daryani, Nasrin Akbarloo, Inhibition by lithium of opioid withdrawal-like syndrome and physical dependency in a model of acute cholestasis in mice, Human Psychopharmacology: Clinical and Experimental, 1998, 13, 6
  68. 68
    Shannon N. Matthews, Clay J. Cockerell, Prurigo nodularis in HIV-infected individuals, International Journal of Dermatology, 1998, 37, 6
  69. 69
    Nora V. Bergasa, E. Anthony Jones, THE PRURITUS OF CHOLESTASIS, Clinics in Liver Disease, 1998, 2, 2, 391

    CrossRef

  70. 70
    Nora V. Bergasa, Babak Mohajer, Isabella M. Maisonneuve, Ann Ho, Nigel T. Maidment, Foster Olive, Mithat Gunduz, Mary Jeanne Kreek, Basal total opioid peptide release in the striatum of rats with cholestasis from bile duct resection: A study by the use of in vivo microdialysis., Life Sciences, 1997, 61, 12, 1169

    CrossRef

  71. 71
    William F. Balistreri, Bile Acid Therapy in Pediatric Hepatobiliary Disease: The Role of Ursodeoxycholic Acid, Journal of Pediatric Gastroenterology & Nutrition, 1997, 24, 5, 573

    CrossRef

  72. 72
    Marco Bertolotti, Anna Ferrari, Giovanni Vitale, Marina Stefani, Tommaso Trenti, Paola Loria, Francesca Carubbi, Nicola Carulli, Emilio Sternieri, Effect of liver cirrhosis on the systemic availability of naltrexone in humans, Journal of Hepatology, 1997, 27, 3, 505

    CrossRef

  73. 73
    Chihiro Tohda, Tomomi Yamaguchi, Yasushi Kuraishi, Increased expression of mRNA for myocyte-specific enhancer binding factor (MEF) 2C in the cerebral cortex of the itching mouse, Neuroscience Research, 1997, 29, 3, 209

    CrossRef

  74. 74
    Pedram Ghafourifar, Ahmad Reza Dehpour, Nasrin Akbarloo, Inhibition by L-NA, a nitric oxide synthase inhibitor, of naloxone-precpitated withdrawal signs in a mouse model of cholestasis, Life Sciences, 1997, 60, 19, PL265

    CrossRef

  75. 75
    Keiichi Musoh, Nobuaki Nakamura, Toshimi Sakurai, Naoki Inagaki, Hiroichi Nagai, Scratching behavior in mice associated with IgE-mediated allergic cutaneous reaction and its pharmacological characterization, Allergology International, 1997, 46, 2, 117

    CrossRef

  76. 76
    Peter F. Whitington, CHRONIC CHOLESTASIS OF INFANCY, Pediatric Clinics of North America, 1996, 43, 1, 1

    CrossRef

  77. 77
    Kathryn L. MacKinnon, Katherine A. Zuzel, Billington David, Hepatic inactivation of Leu-enkephalin, Regulatory Peptides, 1996, 67, 2, 85

    CrossRef

  78. 78
    Leslie Lilly, Carl L. Berg, John L. Gollan, Primary Biliary Cirrhosis, Clinical Immunotherapeutics, 1996, 5, 6, 420

    CrossRef

  79. 79
    Harald Schwörer, Heinz Hartmann, Giuliano Ramadori, Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron, Pain, 1995, 61, 1, 33

    CrossRef

  80. 80
    Nora Valeria Bergasa, The pruritus of cholestasis, Seminars in Dermatology, 1995, 14, 4, 302

    CrossRef

  81. 81
    Mark G. Swain, Alterations in hypothalamic μ-opiate receptor—mediated responses but not methionine enkephalin or proenkephalin messenger RNA levels in rats with acute cholestasis, Hepatology, 1994, 20, 3
  82. 82
    Nora Valeria Bergasa, David W. Alling, John Vergalla, E. Anthony Jones, Cholestasis in the male rat is associated with naloxone-reversible antinociception, Journal of Hepatology, 1994, 20, 1, 85

    CrossRef

  83. 83
    Mukul Khandelwal, Peter F. Malet, Pruritis associated with cholestasis, Digestive Diseases and Sciences, 1994, 39, 1, 1

    CrossRef

  84. 84
    David A. Fisher, Teresa L. Wright, Pruritus as a symptom of hepatitis C, Journal of the American Academy of Dermatology, 1994, 30, 4, 629

    CrossRef

  85. 85
    Jacqueline B. Wahler, Mark G. Swain, Richard Carson, Nora V. Bergasa, E. Anthony Jones, Blood-brain barrier permeability is markedly decreased in cholestasis in the rat, Hepatology, 1993, 17, 6
  86. 86
    Nora Valeria Bergasa, David A. Thomas, John Vergalla, Maria L. Turner, E. Anthony Jones, Plasma from patients with the pruritus of cholestasis induces opioid receptor-mediated scratching in monkeys, Life Sciences, 1993, 53, 16, 1253

    CrossRef

  87. 87
    DAVID A. GILLESPIE, CHRISTOPHER R. VICKERS, Pruritus and cholestasis: Therapeutic options, Journal of Gastroenterology and Hepatology, 1993, 8, 2
  88. 88
    Nora V. Bergasa, Richard B. Rothman, John Vergalla, H. Xu, Mark G. Swain, E.Anthony Jones, Central mu-opioid receptors are down-regulated in a rat model of cholestasis, Journal of Hepatology, 1992, 15, 1-2, 220

    CrossRef

  89. 89
    George Feuer, Carlo J. Di Fonzo, INTRAHEPATIC CHOLESTASIS: A REVIEW OF BIOCHEMICAL-PATHOLOGICAL MECHANISMS, Drug Metabolism and Drug Interactions, 1992, 10, 1-2, 1

    CrossRef

  90. 90
    Peter J. Greco, Jack Ende, Pruritus, Journal of General Internal Medicine, 1992, 7, 3, 340

    CrossRef

  91. 91
    ELWYN ELIAS, PATRIZIA BURRA, Primary biliary cirrhosis: Symptomatic treatment, Journal of Gastroenterology and Hepatology, 1991, 6, 6
  92. 92
    Vinita Gurung, Michael Stokes, Philippa Middleton, Stephen J Milan, William Hague, Jim G Thornton, Interventions for treating cholestasis in pregnancy, The Cochrane Library,
  93. 93
    Nora V. Bergasa, Pruritus,